NCT03920982View on ClinicalTrials.gov

Prognostic Value Serum Concentration of Indoxyl Sulfate During Acute Kidney Injury in Septic Shock Patients.

NACompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

April 1, 2023

Study Completion Date

July 11, 2023

Conditions

Acute Kidney InjurySeptic ShockUremic; ToxemiaMortality

Interventions

DIAGNOSTIC_TEST

Determination of the blood concentration of indoxyl sulfate (IS)

IS concentration will be determined in blood of patients with septic shock and acute kidney injury. IS blood concentration will be done every day during 7 first days after patient will be admitted in intensive care unit. Relation between IS peak serum concentration and mortality at day 28 will be determined.

Trial Locations (1)

80000

CHU Amiens, Amiens

All Listed Sponsors

lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03920982 - Prognostic Value Serum Concentration of Indoxyl Sulfate During Acute Kidney Injury in Septic Shock Patients. | Biotech Hunter | Biotech Hunter